{"id":"W3174342652","doi":"10.1002/ajh.26276","title":"Clinical outcomes after 4.5 years of eliglustat therapy for <scp>Gaucher</scp> disease type 1: Phase 3 <scp>ENGAGE</scp> trial final results","year":2021,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Lysosomal Storage Disorders Research","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":true,"ca_institutions":"Jewish General Hospital","funders":"National Center for Advancing Translational Sciences; Sanofi Genzyme; Sanofi","keywords":"Medicine; Adverse effect; Placebo; Concomitant; Internal medicine; Gastroenterology; Clinical endpoint; Enzyme replacement therapy; Disease; Clinical trial; Pathological; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.001419191,0.0002590561,0.001728464,0.0002726973,0.0000595504,0.00002121321,0.0003181405,0.000146944,0.00005283695],"category_scores_gemma":[0.02191757,0.0002128896,0.0008348388,0.0005484432,0.0007561502,0.000102616,0.00008706718,0.0008144265,0.00002090065],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00006213988,"about_ca_system_score_gemma":0.001574894,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002029434,"about_ca_topic_score_gemma":0.000007067984,"domain_scores_codex":[0.9958906,0.0007788477,0.001634032,0.0004112574,0.0006715424,0.0006137525],"domain_scores_gemma":[0.9910079,0.00567926,0.00106656,0.0005227606,0.001083591,0.0006399941],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.2689845,0.0174318,0.4267778,0.0004807477,0.00501481,0.02255931,0.00410682,0.0000210899,0.001678568,0.0003165271,0.09351926,0.1591088],"study_design_scores_gemma":[0.5141823,0.05581693,0.2219805,0.0005398258,0.001418896,0.00314375,0.01231833,0.0001790815,0.00434132,0.001368439,0.1843922,0.0003183677],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.993189,0.003636251,0.0003255423,0.001430292,0.0005963074,0.0005848417,0.00007225207,0.00001619202,0.0001492709],"genre_scores_gemma":[0.9929133,0.00143165,0.003093447,0.0011416,0.0003730895,0.0000281256,0.00003263447,0.0000615231,0.0009246503],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2451978,"threshold_uncertainty_score":0.9863212,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06823739378827903,"score_gpt":0.4201139288326081,"score_spread":0.3518765350443291,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}